United States · Platforms & data · Finviz

Travere Therapeutics Reports Third Quarter 2026 Financial Results

Published by Finviz · United States 10 h ago

(Nasdaq: TVTX) today reported its third quarter 2026 financial results and provided a corporate update. “Strong execution across our business drove another quarter of significant…

Read the full article on Finviz Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finviz.com)

Also worth reading

MarketBeat

Abbott Laboratories (NYSE:ABT) Stock Sale Revealed by Rep. Thomas H. Kean, Jr.

Seeking Alpha

Michael Burry adds to BYD, SFM, JD, sees up to 140% potential in Fiserv

CNBC

Blackstone president calls for more equity to fund AI buildout as debt risks mount

Investing.com

Why is Virgin Australia stock surging today?

The Motley Fool

Kimberly-Clark Acquires Kenvue. Here’s What Investors Need to Know Ahead of Its Nov. 5 Earnings Report.

MarketWatch